AGN
Allergan Inc
Healthcare
11/11/2013
Presented
| Date | 11/06/2013 |
| Price | $156.53 |
| Market Cap | $27.20B |
| Ent Value | $33.19B |
| P/E Ratio | N/A |
| Book Value | $106.55 |
| Div Yield | N/A |
| Shares O/S | 174.05M |
| Ave Daily Vol | 1,400,000 |
| Short Int | 1.28% |
Current
| Price | $193.02 |
| Market Cap | $63.36B |
| Actavis plc, an integrated specialty pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical products in the United States, Canada, and internationally. It offers generic, branded, branded generic, biosimilar, over-the-counter, biologic, and specialty pharmaceutical products in various formulations, including modified release, solid oral dosage, semi-solids, liquids, gels, transdermal products, and injectables; and develops and out-licenses generic pharmaceutical products to customers through its third-party business. The company also provides pharmaceutical products in various therapeutic categories, such as antibiotics, anti-inflammatories, cardiovascular diseases, dermatology, central nervous system disorders, metabolic disorders, musculo-skeletal system disorders, respiratory system treatment, contraceptives, genito-urinary conditions, pain management, smoking cessation, testosterone replacement, uterine fibroids, infertility, BPH, and OAB; branded specialty pharmaceutical products in women's health, urology, gastroenterology, and dermatology therapeutic categories; and biosimilar products in women’s health, oncology, and other therapeutic categories. In addition, it distributes generic, brand pharmaceutical products, vaccines, injectables, and over-the-counter medicines to independent pharmacies, pharmacy chains, and physicians' offices, as well as alternate care providers, including hospitals, nursing homes, and mail order pharmacies through its distribution facilities in Weston, Florida; Groveport, Ohio; Olive Branch, Mississippi; and Puerto Rico. The company was founded in 1983 and is headquartered in Parsippany, New Jersey with an additional office in Dublin, Ireland. It also has locations in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. |
Please note, this idea was updated on 7/27/2014 and can be read here: Long – Allergan plc (AGN) (Update)
Highlights
Actavis (ACT) reported earnings the week of 10/28 and hit the midpoint of guidance for 2014, sending shares to new highs. The presenter believes the generic and branded pharmaceutical manufacturer’s success/ organic growth stems from its focus on extended release products with little-to-no competition. With effective monopolies and duopolies, ACT can leverage its scale to grow through acquisitions and organically. Two of its largest products are Concerta (a four player market with a generic price at 45%-55% of branded), and Lidoderm (a 2-3 player market if Mylan comes in). Also, its $8.5 billion buyout of Irish drugmaker Warner Chilcott (WCRX) will put ACT among the top specialty pharmaceutical companies in the US and reduce its overall effective tax rate.
◆Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.
◆Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.